Cite
Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model.
MLA
Moghazy, Hoda M., et al. “Liraglutide versus Pramlintide in Protecting against Cognitive Function Impairment through Affecting PI3K/AKT/GSK-3β/TTBK1 Pathway and Decreasing Tau Hyperphosphorylation in High-Fat Diet- Streptozocin Rat Model.” Pflügers Archiv: European Journal of Physiology, vol. 476, no. 5, May 2024, pp. 779–95. EBSCOhost, https://doi.org/10.1007/s00424-024-02933-0.
APA
Moghazy, H. M., Abdelhaliem, N. G., Mohammed, S. A., Hassan, A., & Abdelrahman, A. (2024). Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model. Pflügers Archiv: European Journal of Physiology, 476(5), 779–795. https://doi.org/10.1007/s00424-024-02933-0
Chicago
Moghazy, Hoda M., Nesreen G Abdelhaliem, Sherine Ahmed Mohammed, Asmaa Hassan, and Amany Abdelrahman. 2024. “Liraglutide versus Pramlintide in Protecting against Cognitive Function Impairment through Affecting PI3K/AKT/GSK-3β/TTBK1 Pathway and Decreasing Tau Hyperphosphorylation in High-Fat Diet- Streptozocin Rat Model.” Pflügers Archiv: European Journal of Physiology 476 (5): 779–95. doi:10.1007/s00424-024-02933-0.